• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The COVID-19 pandemic in China: from dynamic zero-COVID to current policy.中国的 COVID-19 疫情:从动态清零到现行政策。
Herz. 2023 Jun;48(3):226-228. doi: 10.1007/s00059-023-05183-5. Epub 2023 Jun 9.
2
Was China's zero-COVID policy the right choice? The multiple factor analysis of variables that affected the course of COVID-19 pandemic in China.中国的“动态清零”政策是正确的选择吗?影响中国 COVID-19 大流行进程的多因素变量分析。
Front Public Health. 2023 Dec 6;11:1252370. doi: 10.3389/fpubh.2023.1252370. eCollection 2023.
3
China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.中国的新冠疫情防控策略及其对全球大流行的影响。
Front Public Health. 2022 Mar 14;10:857003. doi: 10.3389/fpubh.2022.857003. eCollection 2022.
4
Optimizing national border reopening policies in the COVID-19 pandemic: A modeling study.优化 COVID-19 大流行期间的国家边境重新开放政策:建模研究。
Front Public Health. 2022 Nov 30;10:979156. doi: 10.3389/fpubh.2022.979156. eCollection 2022.
5
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
6
Excess All-Cause Mortality in China After Ending the Zero COVID Policy.中国取消“动态清零”政策后全因死亡率的变化。
JAMA Netw Open. 2023 Aug 1;6(8):e2330877. doi: 10.1001/jamanetworkopen.2023.30877.
7
China's community-based crisis management model for COVID-19: A zero-tolerance approach.中国的社区层面新冠疫情危机管理模式:零容忍策略。
Front Public Health. 2022 Jul 22;10:880479. doi: 10.3389/fpubh.2022.880479. eCollection 2022.
8
Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.公共卫生危机比较:中国从 SARS 到 COVID-19 的疫情应对政策。
Glob Public Health. 2021 Aug-Sep;16(8-9):1223-1236. doi: 10.1080/17441692.2021.1919735. Epub 2021 Apr 23.
9
Effect of different resumption strategies to flatten the potential COVID-19 outbreaks amid society reopens: a modeling study in China.不同复课策略对中国社会复课期间潜在 COVID-19 疫情的影响:一项建模研究。
BMC Public Health. 2021 Mar 29;21(1):604. doi: 10.1186/s12889-021-10624-z.
10
Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.新冠疫情下中国卫生信息化的发展、现状与挑战:评估与建议。
J Med Internet Res. 2021 Jun 17;23(6):e27345. doi: 10.2196/27345.

引用本文的文献

1
Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China.新型冠状病毒2型再次感染的流行病学特征及危险因素:中国厦门的一项回顾性队列分析
J Thorac Dis. 2025 Jul 31;17(7):4732-4745. doi: 10.21037/jtd-24-1703. Epub 2025 Jul 28.
2
Anxiety and Depressive Symptoms Among Kidney Transplant Recipients in Post-COVID-19 China: Prevalence and Risk Factors.新冠疫情后中国肾移植受者的焦虑和抑郁症状:患病率及危险因素
Risk Manag Healthc Policy. 2025 Aug 8;18:2601-2611. doi: 10.2147/RMHP.S529124. eCollection 2025.
3
Epidemiological trends of influenza A and B in one hospital in Chengdu and national surveillance data (2019-2024).成都某医院甲型和乙型流感的流行病学趋势及全国监测数据(2019 - 2024年)
Front Cell Infect Microbiol. 2025 Jun 12;15:1603369. doi: 10.3389/fcimb.2025.1603369. eCollection 2025.
4
Associations of sleep characteristics with all-cause, cardiovascular and non-cardiovascular mortality among rural Chinese older adults: a cohort study.中国农村老年人睡眠特征与全因死亡率、心血管疾病死亡率和非心血管疾病死亡率的关联:一项队列研究
BMJ Open. 2025 Jun 22;15(6):e094928. doi: 10.1136/bmjopen-2024-094928.
5
Calculation of COVID-19 disease burden using Monte Carlo simulation with dynamic disability weights and analysis of transmission characteristics.使用动态残疾权重的蒙特卡罗模拟计算COVID-19疾病负担并分析传播特征。
BMC Public Health. 2025 Jun 2;25(1):2041. doi: 10.1186/s12889-025-23273-3.
6
Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: a study on the drug interaction between firmonertinib and paxlovid.超高效液相色谱-串联质谱法同时测定大鼠血浆中伏美替尼及其主要代谢产物AST-5902的方法开发与应用:伏美替尼与帕罗韦德药物相互作用的研究
Front Pharmacol. 2025 May 12;16:1570206. doi: 10.3389/fphar.2025.1570206. eCollection 2025.
7
Diagnostic Delay Among Pulmonary Tuberculosis Patients Before, During and After COVID-19 Pandemic in Yichang City, China: A Longitudinal Study Based on Tuberculosis Surveillance Data.中国宜昌市新冠肺炎疫情前后肺结核患者的诊断延迟:一项基于结核病监测数据的纵向研究
J Epidemiol Glob Health. 2025 May 26;15(1):74. doi: 10.1007/s44197-025-00419-5.
8
Enterprise-led internet healthcare provision in China: insights from a leading platform.中国企业主导的互联网医疗服务:来自领先平台的见解。
Front Digit Health. 2025 Mar 3;7:1491183. doi: 10.3389/fdgth.2025.1491183. eCollection 2025.
9
Correlation Between the Online Visiting Time and Frequency Increase in Telemedicine Services Offered by Health Care Providers Before, During, and After the COVID-19 Pandemic in China: Cross-Sectional Study.中国新冠疫情期间及前后医疗服务提供者提供的远程医疗服务在线访问时间与访问频率增加之间的相关性:横断面研究
J Med Internet Res. 2025 Feb 26;27:e65092. doi: 10.2196/65092.
10
Echoes of Strain: A Two-Year Longitudinal Study on the Impact of China's Zero-COVID Policy on College Students' Insomnia and Depressive Symptoms.压力的回声:一项关于中国新冠疫情防控政策对大学生失眠和抑郁症状影响的为期两年的纵向研究
Nat Sci Sleep. 2025 Jan 13;17:81-96. doi: 10.2147/NSS.S490731. eCollection 2025.

本文引用的文献

1
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy.免疫抑制性肿瘤微环境在抗CD19嵌合抗原受体T细胞治疗后促进弥漫性大B细胞淋巴瘤的肿瘤进展。
Front Med. 2023 Aug;17(4):699-713. doi: 10.1007/s11684-022-0972-8. Epub 2023 Apr 15.
2
Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave.与德尔塔变异株流行相比,奥密克戎变异株流行期间儿童急性 COVID-19 和 MIS-C 的临床严重程度降低,偶发病例增加。
Viruses. 2023 Jan 7;15(1):180. doi: 10.3390/v15010180.
3
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database.COVID-19 临床病程的变异性:一项大型真实世界数据库的回顾性分析。
Viruses. 2023 Jan 3;15(1):149. doi: 10.3390/v15010149.
4
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level.SARS-CoV-2 奥密克戎传播控制的快速高效策略:城市级疫情分析。
Infect Dis Poverty. 2022 Nov 24;11(1):114. doi: 10.1186/s40249-022-01043-2.
5
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.BNT162b2 和科兴疫苗一剂、两剂和三剂对香港 COVID-19 的疫苗有效性:基于人群的观察性研究。
Lancet Infect Dis. 2022 Oct;22(10):1435-1443. doi: 10.1016/S1473-3099(22)00345-0. Epub 2022 Jul 15.
6
Modeling transmission of SARS-CoV-2 Omicron in China.模拟 SARS-CoV-2 奥密克戎在中国的传播。
Nat Med. 2022 Jul;28(7):1468-1475. doi: 10.1038/s41591-022-01855-7. Epub 2022 May 10.
7
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
8
COVID-19 vaccination: The road ahead.COVID-19 疫苗接种:前路漫漫。
Science. 2022 Mar 11;375(6585):1127-1132. doi: 10.1126/science.abn1755. Epub 2022 Mar 10.
9
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
10
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.奥密克戎变异株 B.1.1.529 对 SARS-CoV-2 的复制和致病性减弱。
Nature. 2022 Mar;603(7902):693-699. doi: 10.1038/s41586-022-04442-5. Epub 2022 Jan 21.

中国的 COVID-19 疫情:从动态清零到现行政策。

The COVID-19 pandemic in China: from dynamic zero-COVID to current policy.

机构信息

Department of Cardiology, Zhonghan Hospital, Fudan University, 180 Fenglin Road, 200032, Shanghai, China.

出版信息

Herz. 2023 Jun;48(3):226-228. doi: 10.1007/s00059-023-05183-5. Epub 2023 Jun 9.

DOI:10.1007/s00059-023-05183-5
PMID:37294456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10252163/
Abstract

On 8 January 2023, after 3 years of pandemic control, China changed its management of COVID-19, applying measures against class B infectious diseases instead of Class A infectious diseases. This signaled the end of the dynamic zero-COVID policy and the reopening of the country. With a population of 1.41 billion, China's reopening policy during the COVID-19 pandemic has been characterized by a scientific, gradual, and cautious approach. Several factors contributed to the reopening policy, including an expansion of healthcare capacity, the widespread promotion and uptake of vaccination, and improved prevention and control mechanisms. According to the latest report from the Chinese Center for Disease Control and Prevention, the number of hospitalized COVID-19 patients in the country reached a peak of 1.625 million on January 5, 2023, and has since continued to decline. As of February 13, the number decreased to 26,000: a reduction of 98.4%. Thanks to the efforts of healthcare workers and society as a whole, the country managed to get through the peak of the epidemic in a stable manner.

摘要

2023 年 1 月 8 日,历经 3 年疫情防控,中国对新冠病毒感染正式实施“乙类乙管”,这也标志着中国疫情防控进入新阶段。中国作为拥有 14 亿多人口的大国,在新冠疫情防控期间,坚持科学防治、精准施策、稳中求进,因时因势优化调整防控措施。不断完善医疗救治和预防控制体系,扩大医疗资源和防护物资供给,提升防控和救治能力,加快推进老年人疫苗接种,因时因势科学决策,平稳有序推进实施“乙类乙管”,确保了疫情防控的科学路径、正确方向,平衡了疫情防控和经济社会发展之间的关系。根据中国疾病预防控制中心的最新报告,中国 2023 年 1 月 5 日新冠住院患者达到 162.5 万人的峰值,此后一直在持续下降。截至 2 月 13 日,该数字已降至 2.6 万人,下降了 98.4%。得益于医护人员和全社会的共同努力,中国成功平稳度过了疫情高峰期。